Dr. Pranil K. Chandra, Assistant Vice President and Medical Director of Molecular Pathology and Genomic Medicine Services at PathGroup, has co-authored a publication titled “The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer: A Report of the Association for Molecular Pathology”.
The Association of Molecular Pathology (AMP) report addresses the challenges in defining the clinical utility of molecular diagnostics for inherited disease and cancer, including molecular diagnostic procedures used for diagnosis, prognosis, risk assessment, prediction of future disease, and monitoring and selection of therapies of disease in patients. The report puts forth clinical utility definitions that appropriately recognize the contribution and value of molecular diagnostic testing to improve patient care. Brett Maher Womens Jersey
© 2020 Vesey Street Capital Partners. All Rights Reserved.
Site Designed & Developed by Altastreet